BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
Summary
This item discusses shareholder investigations tied to announced acquisition agreements involving Silence Therapeutics, Option Care Health, RXO, and Sangoma Technologies. Brodsky & Smith asks investors to contact the firm if they want to discuss potential fiduciary-duty claims. The core issue in each case is whether the boards ran a fair process and secured fair value for shareholders. Sangoma Technologies is relevant to software audiences because it operates in telecom software, while the article is primarily about M&A and litigation.
AskAI Classifications
Sectors
HealthTech
Life Sciences and Pharmaceutical
General Healthcare software
Functions
Communication and Collaboration
Sales and Customer Experience
Security
